ResMed Inc. (RMD) reported results for its quarter ended June 30, 2018. ResMed's revenue increased 12% to $623.6 million (up 10% on a constant currency basis), net income increased by 8% and non-GAAP net income surged 24% compared to the same period of the prior year. The company closed out the year with strong performance across all aspects of its business, from solid top-line revenue growth - driven by geographically balanced results across its entire portfolio of offerings - to continued improvements in operating leverage, which has resulted in double-digit bottom-line growth.
http://crweworld.com/article/news-p...ts-for-the-fourth-quarter-of-fiscal-year-2018
- Forums
- ASX - By Stock
- RMD
- ResMed in Numbers - Highlights from its Q4 of FY2018
ResMed in Numbers - Highlights from its Q4 of FY2018
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$29.10 |
Change
0.320(1.11%) |
Mkt cap ! $18.47B |
Open | High | Low | Value | Volume |
$29.11 | $29.39 | $29.06 | $79.72M | 2.743M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1068 | $29.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$29.11 | 5546 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 29.100 |
1 | 523 | 29.090 |
1 | 137 | 29.080 |
1 | 689 | 29.050 |
1 | 102 | 29.010 |
Price($) | Vol. | No. |
---|---|---|
29.230 | 899 | 1 |
29.300 | 1087 | 2 |
29.350 | 330 | 1 |
29.380 | 979 | 2 |
29.390 | 1780 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online